Source:http://linkedlifedata.com/resource/pubmed/id/18065795
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2008-3-24
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1460-2385
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1460; author reply 1460
|
pubmed:meshHeading |
pubmed-meshheading:18065795-Cost-Benefit Analysis,
pubmed-meshheading:18065795-Humans,
pubmed-meshheading:18065795-Hyperparathyroidism, Secondary,
pubmed-meshheading:18065795-Kidney Failure, Chronic,
pubmed-meshheading:18065795-Naphthalenes,
pubmed-meshheading:18065795-Parathyroid Hormone,
pubmed-meshheading:18065795-Renal Dialysis
|
pubmed:year |
2008
|
pubmed:articleTitle |
Cinacalcet: benefit and cost.
|
pubmed:publicationType |
Letter,
Comment
|